On Monday, Pacific Biosciences of California Inc (NASDAQ: PACB) opened higher 4.51% from the last session, before settling in for the closing price of $1.33. Price fluctuations for PACB have ranged from $0.85 to $2.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -23.55% over the last five years. Company’s average yearly earnings per share was noted 12.33% at the time writing. With a float of $264.16 million, this company’s outstanding shares have now reached $300.04 million.
The firm has a total of 575 workers. Let’s measure their productivity. In terms of profitability, gross margin is 16.17%, operating margin of -519.0%, and the pretax margin is -431.71%.
Pacific Biosciences of California Inc (PACB) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pacific Biosciences of California Inc is 11.97%, while institutional ownership is 65.86%. The most recent insider transaction that took place on May 19 ’25, was worth 5,200. In this transaction an insider of this company sold 5,195 shares at a rate of $1.00, taking the stock ownership to the 269,259 shares. Before that another transaction happened on Mar 03 ’25, when Company’s insider sold 12,497 for $1.41, making the entire transaction worth $17,583. This insider now owns 2,225,357 shares in total.
Pacific Biosciences of California Inc (PACB) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 12.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.80% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Check out the current performance indicators for Pacific Biosciences of California Inc (PACB). In the past quarter, the stock posted a quick ratio of 5.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.77, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Analysing the last 5-days average volume posted by the [Pacific Biosciences of California Inc, PACB], we can find that recorded value of 7.24 million was lower than the volume posted last year of 9.94 million. As of the previous 9 days, the stock’s Stochastic %D was 10.93%.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 59.34%, which indicates a significant increase from 21.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1426 in the past 14 days, which was higher than the 0.1029 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3047, while its 200-day Moving Average is $1.5345.
